World Leader in

Cell Expansion & Rejuvenation

What
We do

EnhanceTM
Platform

Proprietary hematopoietic stem cell (HSC) expansion and rejuvenation platform

Learn more

UM171 Cell
Therapy

Allogeneic stem cell therapy to treat blood cancers

Learn more

Pipeline

Pre-clinical pipeline for blood cancers and other diseases

Learn more

News

February 16, 2026

Zemcelpro® (dorocubicel) receives NUB Status 1 in Germany

The NUB designation for Zemcelpro® (dorocubicel) enables hospitals to immediately apply for temporary, supplementary reimbursement for its use. MONTREAL, February 16, 2026 – ExCellThera Inc. (ExCellThera), a world leader in blood stem cell expansion and metabolic fitness, and its wholly owned subsidiary Cordex Biologics (Cordex), announced that Zemcelpro® (dorocubicel), also known as UM171 Cell Therapy, has […]

Read more
See all articles

About us

Who we are

ExCellThera is an advanced clinical-stage company specializing in cell expansion and engineering, providing molecules and bioengineering solutions to expand and modify various cell lines for use in innovative single-use curative therapies for patients with hematological malignancies and other diseases.

Learn more
Symbol